Quest Diagnostics Incorporated
DGX
$175.08
$1.320.76%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.03% | 1.99% | 10.22% | 5.79% | 6.68% |
| Total Depreciation and Amortization | 15.40% | 12.30% | 4.71% | 2.26% | 2.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 58.12% | 37.90% | 55.21% | -34.24% | -54.30% |
| Change in Net Operating Assets | -32.91% | -38.62% | 73.45% | -253.19% | 49.03% |
| Cash from Operations | 12.16% | 4.87% | 29.47% | -9.17% | 0.00% |
| Capital Expenditure | -13.77% | -4.17% | 22.57% | 24.80% | 17.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -180.06% | -254.17% | -174.42% | 61.36% | -931.43% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 211.11% | 197.62% | -145.45% | -200.00% | -250.00% |
| Cash from Investing | -119.53% | -140.15% | -92.69% | 43.99% | -109.77% |
| Total Debt Issued | -15.95% | -28.78% | 60.60% | 25.98% | 1,651.43% |
| Total Debt Repaid | 47.01% | 83.57% | 49.54% | -58.87% | -1,108.51% |
| Issuance of Common Stock | 52.54% | 1.39% | -26.44% | -48.04% | -57.25% |
| Repurchase of Common Stock | 34.90% | 42.24% | 38.85% | 65.51% | 71.99% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.33% | -5.41% | -5.83% | -5.21% | -4.59% |
| Other Financing Activities | 60.75% | 39.53% | 13.75% | 81.29% | -1.90% |
| Cash from Financing | 714.46% | 577.50% | 368.74% | 48.23% | 106.21% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -195.65% | -136.93% | 211.49% | 121.84% | 155.68% |